Source comparison
Examorelin vs Hexarelin: Full Molecular Comparison
Amino Acid Sequence His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2 Sequences are molecularly identical. No structural variation exists between the two names Molecular Weight 887.04 Da Mass spectrometry confirms identical molecular mass. Any supplier variance beyond
This comparison does not assign a generated winner or score.
- Amino Acid Sequence
- His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2
- Sequences are molecularly identical. No structural variation exists between the two names
- Molecular Weight
- 887.04 Da
- Mass spectrometry confirms identical molecular mass. Any supplier variance beyond ±0.5 Da indicates mislabelling or contamination
- GHS-R1a Binding Affinity (Ki)
- 0.7–1.2 nM
- Binding kinetics overlap completely in published radioligand assays. No receptor differentiation occurs
- Regulatory Designation
- INN (International Nonproprietary Name) assigned by WHO
- Research/trade name from early Europeptides development
- Naming convention difference only. Does not indicate formulation or purity variance
- Clinical Trial History
- Used in European Phase II protocols (1995–2000)
- Used in North American and Japanese research protocols (1992–1998)
- Both names reference the same compound tested in overlapping patient populations
- Typical Supplier Purity Range
- 98–99.5% (HPLC)
- Purity standards are supplier-dependent, not name-dependent. Verify via third-party testing regardless of label